Loading...
Neogen Corporation
NEOG•NASDAQ
Healthcare
Medical - Diagnostics & Research
$5.22
$0.10(1.95%)
Neogen Corporation (NEOG) Financial Performance & Income Statement Overview
Review Neogen Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.37%
↑ 12.37%
Operating Income Growth
56.37%
↑ 56.37%
Net Income Growth
58.81%
↑ 58.81%
Operating Cash Flow Growth
-14.05%
↓ 14.05%
Operating Margin
-47.71%
↓ 47.71%
Gross Margin
48.79%
↑ 48.79%
Net Profit Margin
-53.56%
↓ 53.56%
ROE
-16.72%
↓ 16.72%
ROIC
-11.10%
↓ 11.10%
Neogen Corporation (NEOG) Income Statement & Financial Overview
Review Neogen Corporation's (NEOG) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $231.26M | $216.96M | $236.79M | $228.81M |
| Cost of Revenue | $117.93M | $112.04M | $123.31M | $111.93M |
| Gross Profit | $113.33M | $104.93M | $113.48M | $116.88M |
| Gross Profit Ratio | $0.49 | $0.48 | $0.48 | $0.51 |
| R&D Expenses | $5.11M | $5.20M | $5.14M | $4.85M |
| SG&A Expenses | $104.32M | $97.47M | $90.77M | $100.007M |
| Operating Expenses | $570.81M | $102.67M | $95.91M | $104.86M |
| Total Costs & Expenses | $688.74M | $214.71M | $219.22M | $216.79M |
| Interest Income | $774000.00 | $993000.00 | $1.10M | $1.61M |
| Interest Expense | $18.14M | $18.61M | $18.62M | $18.29M |
| Depreciation & Amortization | $749000.00 | $29.80M | $28.86M | $29.65M |
| EBITDA | -$457.48M | $32.81M | $41.67M | $41.67M |
| EBITDA Ratio | -$1.98 | $0.15 | $0.18 | $0.18 |
| Operating Income | -$457.48M | $2.26M | $17.57M | $12.02M |
| Operating Income Ratio | -$1.98 | $0.01 | $0.07 | $0.05 |
| Other Income/Expenses (Net) | -$19.09M | -$17.87M | -$19.44M | -$17.84M |
| Income Before Tax | -$476.57M | -$15.61M | -$6.40M | -$5.82M |
| Income Before Tax Ratio | -$2.06 | -$0.07 | -$0.03 | -$0.03 |
| Income Tax Expense | -$20.29M | -$3.00M | -$984000.00 | -$3.80M |
| Net Income | -$456.28M | -$12.61M | -$5.42M | -$2.02M |
| Net Income Ratio | -$1.97 | -$0.06 | -$0.02 | -$0.009 |
| EPS | -$2.10 | -$0.06 | -$0.03 | -$0.009 |
| Diluted EPS | -$2.10 | -$0.06 | -$0.03 | -$0.009 |
| Weighted Avg Shares Outstanding | $216.81M | $216.70M | $216.61M | $216.60M |
| Weighted Avg Shares Outstanding (Diluted) | $216.81M | $216.70M | $216.61M | $216.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan